MAMMALIAN TARGET OF RAPAMYCIN INHIBITORS AFTER POST-TRANSPLANT HEPATOCELLULAR CARCINOMA RECURRENCE: IS IT TOO LATE?

被引：0
|
作者：
Au, Kin Pan [1 ]
Chok, Kenneth Siu Ho [1 ]
机构：
[1] Univ Hong Kong, Surg, Hong Kong, Peoples R China
来源：
TRANSPLANTATION | 2020年 / 104卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-18.26
引用
收藏
页码：S621 / S621
页数：1
相关论文
共 50 条
  • [41] Pre-transplant alpha-fetoprotein is associated with post-transplant hepatocellular carcinoma recurrence mortality
    Mahmud, Nadim
    John, Binu
    Taddei, Tamar H.
    Goldberg, David S.
    CLINICAL TRANSPLANTATION, 2019, 33 (07)
  • [42] Mammalian target of rapamycin regulates expression of β-catenin in hepatocellular carcinoma
    Feng, Zhenbo
    Fan, Xuejun
    Jiao, Yang
    Ban, Kechen
    HUMAN PATHOLOGY, 2011, 42 (05) : 659 - 668
  • [43] Antitumor effect of sorafenib and mammalian target of rapamycin inhibitor in liver transplantation recipients with hepatocellular carcinoma recurrence
    Jung, Dong-Hwan
    Tak, Eunyoung
    Hwang, Shin
    Song, Gi-Won
    Ahn, Chul-Soo
    Kim, Ki-Hun
    Moon, Deok-Bog
    Ha, Tae-Yong
    Park, Gil-Chun
    Ryoo, Baek-Yeol
    Lee, Kyung Jin
    Kim, Nayoung
    Kwon, Jae-Hyeon
    Jwa, Eun-Kyoung
    Lee, Sung-Gyu
    LIVER TRANSPLANTATION, 2018, 24 (07) : 932 - 945
  • [44] Rapamycin and CCI-779 inhibit the mammalian target of rapamycin signalling in hepatocellular carcinoma
    Hui, Ivan Chun-Fai
    Tung, Edmund Kwok-Kwan
    Sze, Karen Man-Fong
    Ching, Yick-Pang
    Ng, Irene Oi-Lin
    LIVER INTERNATIONAL, 2010, 30 (01) : 65 - 75
  • [45] Post-Transplant Alpha-Fetoprotein Slope: A Strong Predictor of Hepatocellular Carcinoma Recurrence and Survival after Transplantation.
    Dumitra, Teodora
    Dumitra, Sinziana
    Barkun, Jeffrey
    Metrakos, Peter
    Chaudhury, Prosanto
    Paraskevas, Steven
    Deschenes, Marc
    Tchervenkov, Jean
    LIVER TRANSPLANTATION, 2013, 19 : S222 - S222
  • [46] Letter: mechanistic target of rapamycin inhibitors-do they impact on recurrence of hepatocellular carcinoma after liver transplantation? Authors' reply
    Grigg, Sam E.
    Sarri, Gino L.
    Gow, Paul J.
    Yeomans, Neville D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (01) : 117 - 120
  • [47] Post-transplant inflammatory cytokine signature adds value for predicting tumor recurrence after liver transplantation for hepatocellular carcinoma
    Ng, Kevin Tak-Pan
    Liu, Jiang
    Yeung, Oscar Wai-Ho
    Pang, Li
    Shiu, Hoi Chung
    Liu, Hui
    Yang, Xin Xiang
    Chan, Albert Chi-Yan
    Wong, Tiffany Cho-Lam
    Lo, Chung Mau
    Man, Kwan
    HEPATOLOGY INTERNATIONAL, 2023, 17 (06) : 1596 - 1609
  • [48] Post-transplant inflammatory cytokine signature adds value for predicting tumor recurrence after liver transplantation for hepatocellular carcinoma
    Kevin Tak-Pan Ng
    Jiang Liu
    Oscar Wai-Ho Yeung
    Li Pang
    Hoi Chung Shiu
    Hui Liu
    Xin Xiang Yang
    Albert Chi-Yan Chan
    Tiffany Cho-Lam Wong
    Chung Mau Lo
    Kwan Man
    Hepatology International, 2023, 17 : 1596 - 1609
  • [49] REPLY: Mammalian Target of Rapamycin Inhibitors and Survival in Heart Transplant Recipients
    Asleh, Rabea
    Kremers, Walter K.
    Kushwaha, Sudhir S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (24) : 2860 - 2861
  • [50] Regarding the role of post-transplant inflammatory cytokine signature on predicting tumor recurrence after liver transplantation for hepatocellular carcinoma
    Chen, Bing
    Huang, Bojie
    HEPATOLOGY INTERNATIONAL, 2024, 18 (05) : 1591 - 1591
12345